
SpectraScience: Innovations in Cancer Detection
SpectraScience has developed patented platform technology that diagnoses colorectal cancer, which has a market size of $1, 442.6 million.
Read more »
BioLife Solutions: Powering the Preservation Sciences
BioLife Solutions has a strong interest in target markets: regenerative medicine, biobanking, and drug discovery.
Read more »Orexigen: Anti-Obesity Drug Attempting to Enter Multiple Markets
Orexigen Therapeutics is a biopharmaceutical company that focuses its attention on the treatment of one of the most common diseases in existence today, obesity.
Read more »
The 10 “Do’s and Don’t’s” When Networking at a Healthcare Conference
With OneMedForumNY 2013 just one month away (and a few healthcare conferences coming up), we thought it best to step away from our usual editorial functions and instead offer a ‘how to’ on enhancing your conference experience. Below, find 10 (actually, 11) tips to maximizing your conference networking. We’ve scattered in some special tricks, as well.
Read more »PTSD Special Report: Part I, How to Curb a Potential Epidemic
In response to a recent press release from TONIX Pharmaceuticals, a leading company in the exploration of alternative PTSD treatment, we are issuing a 2-part special report looking at recent developments
Read more »Urovalve Bladder Management System Shows Early Promise in Clinical Trial
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.
Read more »Electro-Optical Raises $11.5 Million for Melanoma Device
Electro-Optical Sciences (EOS), an Irvington, NY-based company that’s working on a device for diagnosing melanoma, has raised $11.5 million in […]
Read more »Medical Devices Present Promising Career Alternative
A July 31 CNET.com column says medical devices may be the answer for job seekers who, despite a fascination with […]
Read more »New Cerebral-Aneurysm Device Cleared in Europe
ev3, a Plymouth, MN-based endovascular device firm, has received CE Mark approval for a new product that treats cerebral aneurysm. […]
Read more »